Literature DB >> 8976910

Screening for disease.

W C Black1, H G Welch.   

Abstract

Screening for disease has become a major activity over the last few decades, and the potential for future growth is almost boundless. However, the necessity for and effectiveness of screening has often been overstated with misused survival statistics. Nevertheless, screening with certain radiologic tests may provide modest benefits at acceptable costs under certain conditions. The challenge for the future is to better identify the tests, populations, and other conditions under which screening is appropriate. Various quantitative techniques for eliciting patient preferences [76] and analyzing benefits, harms, and costs over time [77-80] may help us meet this challenge.

Entities:  

Mesh:

Year:  1997        PMID: 8976910     DOI: 10.2214/ajr.168.1.8976910

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  29 in total

1.  Misinterpretation of the chest x ray as a factor in the delayed diagnosis of lung cancer.

Authors:  P M Turkington; N Kennan; M A Greenstone
Journal:  Postgrad Med J       Date:  2002-03       Impact factor: 2.401

Review 2.  Trends in CT colonography.

Authors:  J F Bruzzi; D D Brennan; H M Fenlon
Journal:  Curr Gastroenterol Rep       Date:  2001-10

Review 3.  Progressive multifocal leukoencephalopathy and multiple sclerosis: lessons from natalizumab.

Authors:  Annette Langer-Gould; Lawrence Steinman
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

Review 4.  The significance of quality of life in health care.

Authors:  Robert M Kaplan
Journal:  Qual Life Res       Date:  2003       Impact factor: 4.147

5.  The National Lung Screening Trial: overview and study design.

Authors:  Denise R Aberle; Christine D Berg; William C Black; Timothy R Church; Richard M Fagerstrom; Barbara Galen; Ilana F Gareen; Constantine Gatsonis; Jonathan Goldin; John K Gohagan; Bruce Hillman; Carl Jaffe; Barnett S Kramer; David Lynch; Pamela M Marcus; Mitchell Schnall; Daniel C Sullivan; Dorothy Sullivan; Carl J Zylak
Journal:  Radiology       Date:  2010-11-02       Impact factor: 11.105

6.  Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort.

Authors:  R K Simmons; M Rahman; R W Jakes; M F Yuyun; A R Niggebrugge; S H Hennings; D R R Williams; N J Wareham; S J Griffin
Journal:  Diabetologia       Date:  2010-10-27       Impact factor: 10.122

7.  Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in 161 subjects.

Authors:  Hisanobu Koyama; Yoshiharu Ohno; Atsushi Kono; Daisuke Takenaka; Yoshimasa Maniwa; Yoshihiro Nishimura; Chiho Ohbayashi; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2008-05-06       Impact factor: 5.315

8.  Evaluating randomized trials of screening.

Authors:  H G Welch; W C Black
Journal:  J Gen Intern Med       Date:  1997-02       Impact factor: 5.128

Review 9.  Management of Secondary Genomic Findings.

Authors:  Alexander E Katz; Robert L Nussbaum; Benjamin D Solomon; Heidi L Rehm; Marc S Williams; Leslie G Biesecker
Journal:  Am J Hum Genet       Date:  2020-07-02       Impact factor: 11.025

Review 10.  The ethics of how to manage incidental findings.

Authors:  Carolyn Ells; Brett D Thombs
Journal:  CMAJ       Date:  2014-03-31       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.